lower cost. [3] [4] [5] These advantages can also be found even among recipients aged over 60 years, regardless of donor characteristics. 6 In Brazil, only a few seniors are benefiting from this treatment as of yet, to the detriment of the large share of this population among patients with chronic renal failure. For example, in 2009, about 40% of the more than 50,000 dialysis patients were older than 60 years. 7 However, that same year, only 10.8% of newly enlisted patients on the waiting list for transplant were senior citizens, despite this figure increasing 10 times since 1999. 8 Finally, at the Kidney Hospital (HRIM), responsible for 20% of all kidney transplants performed in the country in the same year, only 12.5% of these transplants were allocated to this age range. 9 As more recent data shows, 7 it is estimated that the number of dialysis patients reached 100,000 in 2013, being 30% the number of patients over age 65 in the last three years, during which period the population enrolled for transplantation in the same age range remained below 15%. 8 Factors such as lower life expectancy, higher association with other comorbidities, surgical risk and potential for serious complications have kept the elderly from having access to transplants.
But there is not yet enough information to justify this conservative approach to treatment of renal failure in these individuals, whom, in a way, are being deprived of this possibility, despite the universal coverage system currently in force in Brazil vis-à-vis organs distribution.
The aim of the study was to compare the clinical and surgical evolution of elderly patients versus controls. Follow up losses were counted out on the last day of follow up recording. Graft loss was defined as return to dialysis or retransplantation.
Methods
This is a retrospective cohort study, from a single center, which included elderly patients (defined as 60 years of age or older) who underwent renal transplantation between 1998 and 2010. We excluded second transplant recipients. For comparative analysis, we made up a control group, with patients older than 18 and less than 60 years of age, matched 1: 1 by gender, year of transplantation and type of donor (living/deceased). Information was obtained through review of medical records, after approval by the local Ethics Committee in Research.
StatiStical analySiS
Continuous variables were presented as mean and standard deviation, and the categorical variables as absolute frequency and percentage. The comparative analysis between two groups was estimated using the unpaired Student t-test for continuous variables and the Pearson's Chi-square test or Fisher's exact test for the categorical variables. Survival curves were obtained using the KaplanMeier method, and comparisons we made using the log-rank test. Logistic regression analysis was used to identify the magnitude of risk factors influence on patient and graft survival suppressing deceased patients and to estimate the relative risk for variables of 
results
During the study period there were about 8,500 transplants carried out at the Kidney Hospital (Hrim). Of these, 376 patients had more than 60 years of age and were followed-up in an outpatient basis at the Public Health Care System (SUS). Among these, 10 were re-transplanted and thus excluded. After pairing with the control group, we had a total sample of 732 patients. Minimum follow-up was 1 day, maximum of 10 years with an average of 5 years (1876 days).
DemOgraphicS
The two groups were compared for the various demographic variables, as per depicted on Table 1 . The older group had a higher frequency of diabetes mellitus as a cause of kidney failure (26% vs. 12%, p < 0.001), a higher percentage of patients were prioritized for lack of vascular access (5.7% vs. 2.5%, p = 0.025), there was higher percentage of women with at least one pregnancy prior to transplantation (87% vs. 72%, p = 0.005) and a higher mean HLA mismatches vis-à-vis the donor (3.1 vs. 2.6, p = 0.001).
In both groups, 75% of the patients received a deceased donor transplant and of these, 25% met expanded donor criteria. Mean donor age was higher in the elderly group (45.6 vs. 42.8 years, p = 0.005). 
Survival analySiS
Patient survival was lower in the elderly group, in five years (76.6 vs. 87.7%, p = 0.001) and in ten years (54.8 vs. 84.3%, p < 0.001, Figure 1 ). The overall graft survival was 52.9% among the elderly and 72.2% among the controls at 5 years of followup (p ≤ 0.001); and 39.6% among the elderly and 66.9% among controls after 10 years (p < 0.001, Figure 2 ). However, survival was similar between the two groups, in five years (86.6 vs. 75.6% vs. 86.3%, p = 0.782) and after ten years of follow-up (76.1% vs. 81.1% vs. 73.8%, p = 0.888, Figure 3 ).
Death with a functioning graft was the main cause of graft loss among the elderly population, accounting for 65% of these. This was also the most common cause of graft loss in the control group, but at a significantly lower frequency (44%, p = 0.023). Among the other causes of graft loss, the first was followed by chronic nephropathy, primary non-function and acute rejection ( Table  2) . As for the causes of death, the most common was infection, followed by cardiovascular disease and cancer. These causes were distributed similarly in both groups (Table 2 ). Induction frequency and the initial immunosuppressive regimen were evenly distributed between the two groups. The elderly had a higher incidence and longer duration of delayed renal graft function (45.6 vs. 36.1%, p = 0.008; 5.8 vs. 4.2 days, p = 0.036), and longer hospital stay (17.5 vs. 13.6 days, p = 0.001; Table 1 ). The incidence of acute rejection was similar between the two groups (24.6 vs. 29.5%, p = 0.134). During the follow-up period, the elderly had higher frequency of readmissions (77.3 vs. 70.5%, p = 0.035), cardiovascular events (12.3 vs. 3.8%, p < 0.001) and neoplasms (6.8 vs. 1.6%, p < 0.001, Table 4 ). On the other hand, immunosuppressive regimen tolerability, as assessed by the need for replacing at least one of dIscussIon This is one of the few Brazilian studies comparing the evolution of renal transplantation in the elderly versus non-elderly recipients in a 10 year-follow-up period. The patient's death was responsible for the significant difference between the overall patient and graft survival curves. However, old age does not constitute an independent factor for allograft poor survival, as shown in graft survival curves suppressing deceased patients (similar to the elderly and non-elderly) and in multivariate analysis (not decisive age for graft loss). In this study, transplant half-life in the elderly group was 8.2 years, while in the control group was longer than 10 years. This result is similar to that found in large survey of the US transplanted population during the same period of time: 8 to 8.8 years between 2000-2005. 10 As for graft survival suppressing deceased patients, studies with smaller populations or with shorter follow-up period also demonstrated the similarity of evolution between youth and elderly groups 11 and, in some cases, higher for the elderly. 12, 13 Probably, as noted in this study, other causes of loss, such as acute rejection and chronic graft nephropathy, most frequently in the younger group, offset the effect of death on graft survival in the elderly group.
Apart from age, diabetes as a cause of renal failure and the type of deceased donor were independent risk factors for patient death (Figures 4  and 5 ). Between these two factors, diabetes mellitus stands out, with a frequency twice as high among Figure 5 . Patient actuarial survival according to the subgroups:: elderly with deceased donor, elderly with live donor, control with deceased donor, control with live donor; by the Kaplan-Meier method-elderly patient survival after 5 years of evolution was similar to that of the deceased donor (75.3%) or live (78.3%); however, lower than the patients in the control group as a deceased donor (87,6%) or live (87.7%) (p < 0.006). Figure 4 . Patient actuarial survival according to the subgroups: diabetic elderly, non-diabetic elderly, diabetic control, non-diabetic control; by the Kaplan-Meier method -Survival of the non-diabetic elderly patient (78.6%) was similar to the diabetic control (78.4%) after 5 years of progression. In comparing the four groups (diabetic elderly 70.3%; nondiabetic control 89%); there was a significant difference (p < 0.001).
elderly patients. By dividing our sample into four distinct subgroups by age and diabetes as cause of renal failure (Figure 4) , we note the survival similarity between non-diabetic elderly patients and diabetic youths after 5 years of progression, confirming the importance of such comorbidity in poor patient outcome. After 5 years, we no longer have similarities between the two curves in this sample, which can be related to the small number of patients remaining after this period.
Regarding graft survival, the determining factors for this outcome were prioritization for vascular access, difficulties for dialysis and diabetes mellitus as a cause of kidney failure. Both factors were found more frequently among elderly recipients (prioritization 5.7 vs. 2.5%, p = 0.025; diabetes mellitus 26 vs. 12%, p < 0.001). This finding confirms the importance of diabetes as a decisive clinical condition in transplant outcome.
Unlike studies in which acute rejection has decisive influence on graft long-term survival, 14, 15 we did not find this correlation in our data. It is noteworthy that we considered all clinical events that determined treatment for acute rejection, regardless of histological confirmation and, in addition, we considered only the first episode, 72% of which occurred in the first six months after transplantation. As shown in previous studies, the occurrence of early rejection episodes and response to therapy might explain the little clinical significance of this event. 16 There were more postoperative complications (dehiscence, fistula, hernia and dilated bladder) among the elderly and also differences in surgical technique: 72% of young people were submitted to the conventional technique (Lich-Gregoir); while only 56% of the elderly were subjected to this technique. In other studies, [17] [18] [19] the frequency of urologic complications varies from 1.8 to 20.8%, and is mainly related to being a male recipient from a deceased donor -characteristics for which there were no differences in the groups.
In our hospital, the surgical technique is decided upon during surgery and there is no systematic preoperative evaluation for patients. Less use of the conventional surgical technique suggests greater difficulty with the elderly. A recent meta-analysis shows the association between the conventional technique and lower risk of urinary fistula, as we found here. 20 It is possible that the higher number of surgical complications has influenced length of stay, making it higher for the elderly group, 17. 5 days on average against 13.6 days among the younger patients (p < 0.001), which increases cost and risk for the pacient. 21, 22 Thus, it is possible that a regular preoperative urological evaluation would specifically benefit the elderly group.
The overall incidence of at least one episode of acute rejection in this population was 27% in 10 years. Risk factors independently associated with this outcome in multivariate analysis were black ethnicity, negative serology for CMV and length of stay greater than 10 days, characteristics for which the elderly and control groups were similar. Despite the tendency to lower incidence of rejection among elderly patients in other studies, 12, 23, 24 there was no significant difference in our sample. However, for risk factors traditionally associated with acute rejection, such as pregnancy, mismatches and delayed graft function, the elderly group was more exposed. It is possible that a larger sample would be needed to guide conclusions accordingly.
In our study, the incidence of post-transplant cardiovascular events was three fold higher among the elderly. We believe that diabetesthe most common cause of CKF in this group when compared to young patients, has been one of the factors responsible for this poor outcome; moreover, unconventional factors associated with coronary inflammation and calcification, such as longer time on dialysis, may have accounted for the higher frequency of coronary events in this group. Among the elderly, 26 deaths (26.8%) were caused by cardiovascular disease while there were only eight (17.8%) of the control patients who died from this cause.
The overall frequency of malignancies was 4.23%. Among the elderly, tumors were four times more frequent in the younger age group, and, moreover, caused twice as many deaths. Possible mechanisms associated with increased incidence of cancer in the elderly include the time required for carcinogenesis, increased tissue exposure to environmental carcinogens and imunoscenescense. 25 As in other retrospective studies of database analysis, the reliability of available data in the medical records or even their lack thereof, limits the scope of the results. Second, the fact that the study comes from a single center limits the extrapolation of the results to other populations.
In conclusion, this retrospective cohort from a single center, advanced age per se, ruling out patient's death as a cause of graft loss, did not represent an independent factor of poor prognosis of renal transplantation in the long term when compared to a younger population, matched by donor type, immunosuppression and year of transplant. However, the higher prevalence of diabetes mellitus was a determining factor of higher mortality among this group, determining worse results in terms of overall survival.
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